Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid, a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development.
- Author
- Stef De Lombaerde, Sara Neyt (UGent) , Ken Kersemans (UGent) , Jeroen Verhoeven (UGent) , Lindsey Devisscher (UGent) , Hans Van Vlierberghe (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8522278
- MLA
- De Lombaerde, Stef, et al. “Synthesis, in Vitro and in Vivo Evaluation of 3β-[18F]Fluorocholic Acid, a Radiolabeled Bile Acid to Detect Drug-Induced Cholestasis in Preclinical Drug Development.” 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent, Belgian Society of Nuclear Medicine (BELNUC), 2017, pp. 140–41.
- APA
- De Lombaerde, S., Neyt, S., Kersemans, K., Verhoeven, J., Devisscher, L., Van Vlierberghe, H., … De Vos, F. (2017). Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid, a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development. 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent, 140–141. Belgian Society of Nuclear Medicine (BELNUC).
- Chicago author-date
- De Lombaerde, Stef, Sara Neyt, Ken Kersemans, Jeroen Verhoeven, Lindsey Devisscher, Hans Van Vlierberghe, Christian Vanhove, and Filip De Vos. 2017. “Synthesis, in Vitro and in Vivo Evaluation of 3β-[18F]Fluorocholic Acid, a Radiolabeled Bile Acid to Detect Drug-Induced Cholestasis in Preclinical Drug Development.” In 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent, 140–41. Belgian Society of Nuclear Medicine (BELNUC).
- Chicago author-date (all authors)
- De Lombaerde, Stef, Sara Neyt, Ken Kersemans, Jeroen Verhoeven, Lindsey Devisscher, Hans Van Vlierberghe, Christian Vanhove, and Filip De Vos. 2017. “Synthesis, in Vitro and in Vivo Evaluation of 3β-[18F]Fluorocholic Acid, a Radiolabeled Bile Acid to Detect Drug-Induced Cholestasis in Preclinical Drug Development.” In 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent, 140–141. Belgian Society of Nuclear Medicine (BELNUC).
- Vancouver
- 1.De Lombaerde S, Neyt S, Kersemans K, Verhoeven J, Devisscher L, Van Vlierberghe H, et al. Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid, a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development. In: 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent. Belgian Society of Nuclear Medicine (BELNUC); 2017. p. 140–1.
- IEEE
- [1]S. De Lombaerde et al., “Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid, a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development.,” in 18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent, Ghent, Belgium, 2017, pp. 140–141.
@inproceedings{8522278, articleno = {{abstract PHARM 03}}, author = {{De Lombaerde, Stef and Neyt, Sara and Kersemans, Ken and Verhoeven, Jeroen and Devisscher, Lindsey and Van Vlierberghe, Hans and Vanhove, Christian and De Vos, Filip}}, booktitle = {{18th Symposium of the Belgian Society of Nuclear Medicine, 5th to 7th May 2017, Ghent}}, language = {{eng}}, location = {{Ghent, Belgium}}, pages = {{abstract PHARM 03:140--abstract PHARM 03:141}}, publisher = {{Belgian Society of Nuclear Medicine (BELNUC)}}, title = {{Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid, a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development.}}, year = {{2017}}, }